Memis, DilekOtkun, MueserrefBahar, MeralSut, Necdet2025-01-272025-01-2720091301-3149https://hdl.handle.net/20.500.12428/2396314th World Congress of Anaesthesiologists -- MAR, 2008 -- Cape Town, SOUTH AFRICAObjectives: We studied in vivo growth of Escherichia coli in atracurium, rocuronium, mivacurium, cisatracurium, pancuronium, and vecuronium. Patients and Methods: The pathogen was exposed to atracurium, rocuronium, mivacurium, cisatracurium, pancuronium and vecuronium for 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, and 24 h at room temperature, respectively. Results: The mean colony counts of Escherichia coli after exposure to rocuronium was significantly lower than the counts after exposure to atracurium, mivacurium, cisatracurium, pancuronium and vecuronium (p=0.002, 0.000, 0.000, 0.001, and 0.002, respectively). No significant difference was found with respect to the mean colony counts with atracurium, mivacurium, cisatracurium, pancuronium and vecuronium (p<0.05). Conclusion: Rocuronium had more powerful antimicrobial effects than the other neuromuscular agents.eninfo:eu-repo/semantics/closedAccessAtracuriumrocuroniummivacuriumcisatracuriumpancuroniumvecuroniumbacterial contaminationEscherichia coliConference Object262100104Q4WOS:000267718200002